Video

Pathophysiology of AD Treatments

Author(s):

Andrew Blauvelt, MD

Andrew Blauvelt, MD, provides an overview of the significance of JAK/Stat pathway inhibition in targeting the pathophysiology of atopic dermatology (AD).

Related Videos
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists
What to Look Forward To at the Fall Clinical Dermatology Conference, with Raj Chovatiya, MD, PhD
A panel of 3 experts on atopic dermatitis
Related Content
Despite Guidelines, Systemic Corticosteroids Remain Widely Prescribed for Atopic Dermatitis
October 26th 2024

Despite Guidelines, Systemic Corticosteroids Remain Widely Prescribed for Atopic Dermatitis

Tim Smith
Default thumbnail for The Medical Sisterhood with Mona Shahriari, MD
October 18th 2024

The Medical Sisterhood: Motherhood in Medicine, with Alexandra Golant, MD

Mona Shahriari, MD, FAAD
New Phase 3b Findings Suggest Lebrikizumab Improved Skin, Itch for Atopic Dermatitis
October 25th 2024

New Phase 3b Findings Suggest Lebrikizumab Improved Skin, Itch for Atopic Dermatitis

Tim Smith
The Medical Sisterhood: Confronting Imposter Syndrome, with Tina Bhutani, MD, MAS
September 30th 2024

The Medical Sisterhood: Confronting Imposter Syndrome, with Tina Bhutani, MD, MAS

Mona Shahriari, MD, FAAD
Creative Treatment Options for Dermatology Practice, with Elizabeth Swanson, MD
October 24th 2024

Creative Treatment Options for Dermatology Practice, with Elizabeth Swanson, MD

Tim Smith
Raj Chovatiya, MD, PhD: Pathophysiology, Diagnosis of Chronic Hand Eczema
October 24th 2024

Raj Chovatiya, MD, PhD: Pathophysiology, Diagnosis of Chronic Hand Eczema

Tim Smith
© 2024 MJH Life Sciences

All rights reserved.